Pharmaceutical Industry Today
Frozen Shoulder Syndrome Market Size, Share, Industry, Forecast and outlook (2023-2030)
Frozen Shoulder Syndrome Market Overview
Market for Frozen Shoulder Syndrome Predicted to Surge with Increasing Incidences
The global market for frozen shoulder syndrome (FSS) is expected to witness substantial growth, with estimations pointing towards a high Compound Annual Growth Rate (CAGR) during the forecast period spanning from 2023 to 2030.
Frozen shoulder, medically termed adhesive capsulitis, is characterized by stiffness and pain in the shoulder joint. Symptoms typically develop gradually, worsen over time, and resolve within one to three years.
Frozen Shoulder Syndrome Market Dynamics
The surge in incidences of frozen shoulder is anticipated to be a primary driver for market growth. Factors such as the high prevalence of diabetes and cardiovascular diseases are likely to elevate the risk of developing frozen shoulder.
Recent statistics suggest that the prevalence rate of frozen shoulder ranges between 2 to 5 percent of the general population, predominantly affecting individuals aged 40 to 60 years. While men are less frequently affected than women, there is no racial preference. Notably, around 70% of individuals afflicted with frozen shoulder are females.
Moreover, the prevalence of diabetes and cardiovascular diseases is significantly contributing to the increased risk of frozen shoulder development. The global prevalence of diabetes is projected to escalate from 9.3% in 2019 to 10.2% by 2030, with cardiovascular diseases being one of the leading causes of mortality worldwide.
To know more Insights Download Sample
Impact of COVID-19 on Frozen Shoulder Syndrome Market
The COVID-19 pandemic has substantially impacted the healthcare industry, leading to delays in treatment and disrupting healthcare services. Lockdown measures imposed by governments globally have further exacerbated the situation, causing a considerable setback in various sectors, including the frozen shoulder syndrome market.
Frozen Shoulder Syndrome Market Segment Analysis
Physical therapy emerges as a dominant segment in the market for frozen shoulder syndrome treatment. It plays a crucial role in enhancing motion and alleviating pain associated with adhesive capsulitis. Hospitals are expected to witness significant growth, owing to the availability of advanced medical equipment and structured physiotherapy treatments.
Frozen Shoulder Syndrome Market Geographical Share
North America is poised to dominate the frozen shoulder syndrome market, attributed to advancements in research and development, coupled with the introduction of technologically advanced products. The region exhibits a higher prevalence of frozen shoulder incidences, particularly among individuals aged 40 to 60 years.
Frozen Shoulder Syndrome Market Competitive Landscape
Key players in the frozen shoulder syndrome market include GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc., Vintage Pharma, Dr. Reddy's Laboratories Ltd, Marksans Pharma, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Perrigo Company plc, Johnson & Johnson Services, Inc., Shanghai Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical Group Co., Ltd., and Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.
Related Reports:
Hunter Syndrome Treatment Market
Usher Syndrome Treatment Market
Klinefelter Syndrome Treatment Market
Carcinoid Syndrome Diarrhea Treatment Market
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
Contact Us -
Name: Sai k
Designation: Sales & Senior Business Consultant
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!